Abstract
The caspase activation and recruitment domain (CARD) mediates protein-protein interactions in apoptotic and inflammatory signaling pathways. In humans, more than 30 proteins contain a CARD, several of which have been reported to polymerize into helical filaments. Here we found that the CARD from the apoptotic protease caspase-9 (C9CARD) self assembles into filaments in vitro at physiological pH and salt concentrations. The C9CARD more readily polymerizes under low-salt or mildly acidic conditions, suggesting a significant role for electrostatic interactions in mediating filament formation. Using NMR spectroscopy, we determined the pKa of the lone histidine residue, H38, which supports a role for histidine protonation in enhancing filament formation. Indeed, mutation of H38 to introduce a positive (H38R) or negative (H38D) charge, or to remove the pH-dependence of the side chain at this site altogether (H38N), dramatically alters the filament propensity of the domain. Using cryo-election microscopy, we determined 3.4- and 3.2-Å structures of the wild-type and H38R C9CARD filaments, respectively, which provide new insights into the molecular basis of C9CARD polymerization and its pH dependence via H38.
Keywords: death domain folds, caspase activation and recruitment domain (CARD), helical filament, cryo-EM, NMR
Introduction
Apoptosis, or programmed cell death, is an intricate biochemical signaling cascade that eliminates damaged cells and aids in the regulation of cellular differentiation and homeostasis1–3. Dysregulated apoptosis plays a central role in unregulated inflammatory responses, neurodegenerative diseases, and cancer development4–7. Caspase-9 (C9), a cysteine-aspartic protease8,9, plays a key role as an initiator of the intrinsic apoptotic pathway10,11 and regulates cell death processes by cleaving and activating downstream effector caspases, such as C3 and C7 12–14. Under basal conditions, C9 is present as an inactive monomer and requires clustering and activation by the apoptosome10,15,16, a heptameric scaffold comprising Apaf-1, ATP, and cytochrome C. While the role of C9 in activating effector caspases is well established, it is increasingly clear that C9 cleaves hundreds of substrates with diverse implications17,18.
At the molecular level, C9 is a 416-residue protein that is comprised of a caspase activation and recruitment domain (CARD, residues 1–96), an interdomain linker, and a protease domain (residues 139–416). Activation of the protease domain involves substrate-driven, proximity-induced dimerization on the apoptosome platform19,20. Protein engineering approaches have further demonstrated that C9 can be activated via recruitment to synthetic platforms or by constitutive dimerization of the protease domain21. The dimerization-dependent activity of C9 was leveraged as a safety switch in adoptive T-cell therapy, whereby the expression of a chimeric protein comprising the protease domain of C9 and a chemically-inducible dimerization domain enables targeted and rational control over C9 activation and cell death22. Moreover, the activation or catalytic activity of C9 can be inhibited allosterically by post-translational modifications that are distal from the active site 23–28, as well as by zinc and peptide binding to other allosteric sites on the protease domain29,30. More generally, allostery in caspase protease domains appears to be widespread 31–38, including in C9 where it displays half-of-sites reactivity 19,20, which is an extreme form of negative cooperativity.
The N-terminal CARD domain belongs to the death-domain fold (DDF) superfamily, which fold into conserved six-helix bundles and mediate protein-protein interactions39–41. The DDF superfamily comprises four sub-families that include the CARD, death domain (DD), death effector domain (DED), and pyrin domain (PYD). DDFs primarily make homotypic interactions within sub-families (CARD-CARD, PYD-PYD, etc.) with remarkable specificity40. In C9, its CARD (C9CARD) mediates recruitment to the apoptosome platform via CARD-CARD interactions with Apaf-1CARD. The CARD-CARD complex forms a helical oligomer or disk 15,42–46, and the same helical-disk architecture involving C9CARD and Apaf-1CARD has been observed in cryo-electron microscopy (EM) structures of the apoptosome:caspase-9 complex47,48. In full-length C9, the CARD appears to tumble independently of the protease domain20, although transient inter-domain interactions may influence substrate recruitment49. CARDs often use multiple interfaces to interact with themselves and others, including in C9 where the C9CARD:Apaf-1CARD complex involves three different interfaces43,45,48. The locally asymmetric binding interfaces among CARD complexes can lead to complex modes of homo- and hetero-oligomerization, such as polymerization into helical filaments50–58 and the formation of biomolecular condensates via liquid-liquid phase separation59. For caspases, the formation of supramolecular complexes via DDF self-assembly dramatically increases the local concentration of their protease domains, leading to rapid activation. For example, filament formation was shown to play a role in the activation of the CARD-containing C151 as well as the tandem DED-containing C860,61.
Here, we report that the C9CARD polymerizes into filaments in vitro and present a 3.2-Å cryo-EM structure of the C9CARD filament. We dissected the biophysical determinants of C9CARD self-assembly, and by manipulating the pH or salt concentration we identified conditions that enhance C9CARD filament formation. We identified a histidine “switch” (H38) whose protonation stimulates filament assembly, and we found that the mutation H38R enhances filament propensity. We subsequently determined a 3.4-Å cryo-EM structure of the H38R variant of C9CARD, which serves as a mimic of the histidine-protonated form. Other mutations at this position to introduce a negative charge (H38D) or non-titratable polar group (H38N) decrease filament propensity, suggesting that H38 may function as a pH sensor that regulates filament assembly.
Results
We expressed and purified recombinant, 15N-labeled labeled C9CARD for NMR spectroscopy (Figure 1A). The two-dimensional 1H-15N heteronuclear single-quantum coherence (HSQC) spectrum of the 15N-labeled C9CARD at pH 6.5 and room temperature confirmed that our construct is folded under these conditions with the expected number of backbone amide signals. We also observed an additional 10 signals from aliased Arg Nε-Hε groups, which contain 15N chemical shifts near 85 ppm, as confirmed by increasing the 15N spectral width (Supplementary Figure 1). Next, we recorded triple-resonance NMR data on a 13C,15N-labeled sample and assigned the backbone, Cβ, and Arg Nε-Hε resonances. The secondary 13Cα chemical shifts indicate that the six helices are formed in solution (Figure 1B), including a kink in helix-1. This is further confirmed by TALOS-N-derived secondary structure determination (Supplementary Figure 2). 1HN temperature coefficients suggest that the secondary structure elements are stably hydrogen-bonded in solution (Figure 1C), although possible fraying of helices may be occurring at the N- or C-terminal ends of helix-1 and helix-2. Moreover, 15N spin relaxation experiments confirm that the C9CARD is monomeric in solution under these conditions with a rotational correlation time of approximately 6.5 ns (Figure 1C). This falls between an empirical value of 7 ns for a protein of this molecular mass62 (from a standard curve obtained 5 °C lower than our conditions), as well as the value predicted by HydroNMR (5.5 ns) using a crystal structure of C9CARD that lacks six residues found in our construct. To test for transient oligomerization that may slightly increase the rotational correlation time, we also measured 15N Carr-Purcell-Meiboom-Gill relaxation dispersion experiments in the range of 20–35 °C; however, we did not detect any millisecond-exchange contributions to the 15N transverse relaxation rate (Supplementary Figure 2). Thus, the C9CARD is folded and monomeric under these conditions, giving rise to high-quality NMR data in solution.
Figure 1. C9CARD polymerizes from a monomeric state into filaments.
(A) 2D 1H-15N HSQC spectrum of uniformly 15N-labeled C9CARD in 25 mM HEPES, 50 mM NaCl, 5 mM TCEP, 0.5 mM EDTA at pH 6.5 and 25 °C. (B) Secondary 13Cα chemical shifts (Δδ13Cα) and (C) 1HN temperature coefficients (d1H/dT) for the C9CARD. Residues with d1H/dT values below −4.0 ppb/K, suggestive of non-hydrogen-bonded amides, are shown in orange. (D) 15N R1 and (E) 15N R1ρ relaxation rates recorded at 25 °C and a static magnetic field strength of 14.1 T (600 MHz). The 15N spin-lock field strength used for the R1ρ experiment was 2 kHz. (F) Representative negative-stain EM image of C9CARD filaments that were obtained from a sample in the absence of salt at pH 5.5 where the maximum solubility of C9CARD is 150 μM (vide infra).
C9CARD self-assembles into filaments
During the NMR sample preparation, we noticed that C9CARD aggregated above protein concentrations of ca. 0.3 mM in salt-free buffers. Interestingly, the addition of 500 mM NaCl to the C9CARD increased its solubility to above 3 mM protein concentration (Figure 1D), suggesting that salt ions screen out electrostatic interactions between C9CARD molecules that otherwise cause aggregation. Indeed, despite having an expected net charge of zero at pH 6.5, the primary structure of C9CARD is significantly enriched in charged residues, with nearly 33% of the sequence comprising R, K, D, and E, and equal numbers of positively charged (15 Arg, 1 Lys) and negatively charged residues (9 Asp, 7 Glu) (Supplementary Figure 3).
We next sought to test the hypothesis that the aggregates of C9CARD are filaments. To this end, we used negative-stain EM to examine the properties of aggregates that were obtained from a sample of C9CARD in salt-free buffer at pH 7. We observed filament-like structures with an average diameter of approximately 10 nm in the negative-stain EM micrographs (Figure 1E).
Protonation of H38 promotes filament assembly
Having established that the C9CARD forms filaments, as observed by nsEM, we next sought to find solution conditions that promote its filament-forming propensity. To this end, we screened the effects of pH and salt concentration on the stability and solubility of the C9CARD. Notably, the thermodynamic stability of the C9CARD was markedly reduced as the pH was lowered from 7 to 5.5 (Figure 2A), with a concomitant decrease in solubility (Figure 2B). We confirmed by nsEM that the aggregates that formed under acidic conditions were also filamentous (Supplementary Figure 4). Since these experiments used only the isolated CARD domain, we tested whether inclusion of the interdomain linker (residues 100–138) and the protease domain (residues 139–416) impacted filament formation. We purified the C9CARD+linker construct (residues 1–138) and full-length C9 (1–416) harboring an inactivating C287A mutation that prevents auto-proteolysis of the p20-p10 linker 63. As compared to the isolated CARD domain, both the C9CARD+linker and full-length C9C287A were less prone to aggregate (Figure 2B). We collected negative-stain EM data to visualize the aggregates formed by these longer constructs, finding that the majority of aggregates were amorphous, although several filaments could be identified (Supplementary Figure 5). Thus, we proceeded to structurally characterize the isolated C9CARD filaments henceforth.
Figure 2. H38 protonation and the H38R mutation destabilize the CARD and enhance filament assembly.
(A) DSF-based thermal melt of C9CARD in 25 mM HEPES, 2 mM DTT at pH 7 (blue) or pH 5.5 (orange). The normalized, negative derivative of the change in relative fluorescence units (RFU) with temperature is shown on the y-axis. (B) Csat measurements for different variants of C9 at pH 7 (blue) or pH 5.5 (orange). The buffer is the same as panel A. (C) Structure-based prediction of H38’s pKa as a function of the input structure (black, filled). AF2 corresponds to C9 model deposited the AlphaFold Protein Structure Database. The NMR-derived, experimentally determined pKa value for H38 is shown in white. (D) Variation in the H38 13Cε chemical shift as a function of the pH, with the solid line corresponding to a fit to the Henderson-Hasselbalch equation. The inset shows the distribution of pKa values obtained from a bootstrap error analysis, with the orange line positioned at the mean value of 6.03. (E) DSF-based thermal melt of C9CARD variants H38R (red), H38D (green), and H38N (purple). The curves are compared to the WT C9CARD at pH 7 (blue line) or pH 5.5 (orange line). The inset depicts the derived melting temperatures for each variant. (F) Csat determination for the H38 variants at pH 5.5 and 25 °C. The H38R variant is less soluble than the wild-type CARD.
Our observations suggest that the protonation of one or more titratable side chains destabilizes the C9CARD at pH 5.5 and enhances its propensity to self-assemble into filaments. Among its titratable side chains, the C9CARD contains a single histidine residue (H38) with a theoretical pKa of 6.5 that falls within the pH range described above (Figure 2C). However, pKa values can be dramatically shifted away from their theoretical values by local interactions, including electrostatics64–66. For this reason, we first used PROPKA67 to perform C9CARD structure-based pKa prediction (PDB/chain: 4rhw/E, 3ygs/P, 5wvc/B, AlphaFoldDB/A, 5juy/O, 5wve/S), which returned a mean H38 pKa value of 6.7 ± 0.4 (6.61, 6.20, 7.33, 6.15, 6.82, and 6.82, respectively) (Figure 2C). We then experimentally determined the pKa of H38 via NMR spectroscopy to monitor pH-induced changes to the 13Cε chemical shift of H38 (Figure 2D). Quantitative analysis revealed an apparent pKa of 6.03 ± 0.04 (Figure 2D), which indicates that H38 is, indeed, predominantly protonated at pH 5.5 where C9CARD exhibits enhanced filament propensity. Given the large number of acidic side chains in C9CARD (9 Asp, 7 Glu), it is also likely that one or more sites are titrating in the pH range below 5.
H38R mutation mimics the low-pH state and triggers filament assembly
Given that H38 is mostly protonated at pH 5.5 where the C9CARD is highly filamentous, we next evaluated the impact of altering the electrostatic properties at this position while pH remains neutral. To this end, we created three variants of the C9CARD in which we altered the residue at position 38 to be positively charged (H38R), negatively charged (H38D), or polar but not titratable (H38N) (Figure 2E). We then measured the melting temperature and solubility of each variant at neutral pH. We observed that the H38R variant (Tm = 41 °C) was destabilized relative to the wild-type C9CARD (47 °C) as well as the H38D (47 °C) and H38N (49 °C) variants (Figure 2E). Indeed, the melting temperature of the H38R variant at pH 7 resembles that of the wild-type C9CARD at pH 5.5, which further indicates that a positive charge at this position is destabilizing at neutral pH. By contrast, the H38D and H38N variants melt at the same or higher temperature as the wild-type C9CARD at neutral pH.
We observed similar trends with protein solubility: under identical solution conditions (25 mM MES, 2 mM DTT, pH 5.5), the H38R variant aggregated at a nearly 6-fold lower protein concentration as compared to the wild-type CARD (Figure 2F, Supplementary Figure 7). Under these conditions, H38 in the wild-type C9CARD is predominantly, but not fully protonated (ca. 25%/75% un/protonated at pH 5.5 with pKa = 6.03). The six-fold lower Csat of H38R suggests that the positive charge of the Arg head group, with an expected pKa above 10, plays a role in polymerization. By contrast, H38D and H38N remained soluble up to protein concentrations that were respectively two- and more than 20-fold higher than the wild-type C9CARD (Figure 2F), with no aggregates of H38N detected in this experiment.
Using nsEM, we observed filaments of H38R that resembled those formed by the wild-type C9CARD with an average diameter near 10 nm (Supplementary Figure 7). Similarly, we observed filaments for the H38D variant that only formed at significantly higher protein concentrations as compared to the H38R variant (Supplementary Figure 8), suggesting that altering the residue at this site modulates but does not inhibit filament formation. Collectively, our results indicate that a positive charge at position 38 thermodynamically destabilizes the CARD, lowers its solubility, and promotes self-assembly into the filamentous state. These results support the notion that H38 is the primary pH sensor in the range of 7 to 5.5, where its protonation (or H38R mutation) contributes to polymerization.
Next, we analyzed the variation in residue type at this position of the CARD in more than 250 different C9 orthologs. The most common residue type at this position is the negatively charged Asp (n = 179), followed by A (16), P (14), T (12), L (10), H (7), N (7), G (6), and S (6) (Supplementary Figure 8). We did not find a positively charged residue at this position in any of the examined organisms. In agreement with our biophysical results above, these bioinformatics data indicate that positively charged residues are not preferred at this position in C9CARD.
H38 protonation alters its side-chain dynamics and clashes with the helix dipole
H38 is a solvent-exposed residue in the C9CARD that is located close to two negatively charged residues (E41, D42). It is, therefore, unclear why the H38R mutation and protonation of H38 significantly destabilize the domain. Indeed, the structure-based predictors of protein stability FoldX68 and DDmut69,70 do not report any significant changes to the stability of the C9CARD following the H38R mutation (ΔΔG = −0.19 kcal mol−1 vs. RMSE of 1.37 kcal/mol on cross-validation set). This contrasts with our experimental observations (Figure 2).
Thus, to better understand why H38 protonation and H38R are destabilizing, we performed all-atom molecular dynamics (MD) simulations of the C9CARD as a function of the H38 protonation state or with the H38R mutation. In the crystal structure of C9CARD (PDB: 4rhw, chain E), which was crystallized at pH 5.5, the side chain of H38 is surrounded by nearby charged residues in helix-3, forming interactions with the side chains of E41 (3.6 Å) and D42 (3.7 Å). The acidic pH of the crystallization buffer suggests that H38 was likely protonated. For the C9CARD with H38 in either the neutral or protonated form, our MD simulations show that the global fold of the domain is preserved with a mean backbone and side chain root-mean-square deviation (RMSD) values near 2 and 3 Å, respectively, over the course of the trajectory (Supplementary Figure 9). For most backbone atoms, per-residue root-mean-square fluctuation (RMSF) values indicate negligible differences (± 0.1 Å) for the majority of sites in C9CARD (Supplementary Figure 9). In the protonated form, locally elevated backbone RMSF values are only observed at the N-terminus for residues M1 (H38 neutral – H38 protonated = −1.0 Å) and D2 (−0.3 Å), at a few sites in helix-1 (residues 11–13 and 16; −0.2 to −0.3 Å), in loop 4,5 (65–68, −0.2 to −0.8 Å), and at the C-terminus (94,95; −0.3 Å). On the other hand, locally decreased RMSF values in protonated-H38 are seen in loop 3,4 (residues 44–46, 47; 0.15-to-0.2 Å) near H38 itself (Supplementary Figure 9). For H38 itself, there is no difference in backbone RMSF for the neutral or protonated state. However, among side-chain heavy-atom RMSF values, H38 shows the second largest difference in RMSF values (Supplementary Figure 9) (neutral – protonated = −0.5 Å), pointing to increased structural dynamics in the protonated form. In addition, the sites discussed above with non-zero differences in backbone RMSF values similarly exhibit non-zero differences in side-chain RMSF values (Supplementary Figure 9).
Consistent with the above RMSD and RMSF analyses, we found that H38 protonation does not cause any significant changes to the backbone phi and psi dihedral angle distributions that were observed in the H38-neutral state. Instead, we observed large redistributions to some side-chain rotamer populations, emanating from H38 itself (Figure 3A, 3B, 3C). In its neutral form, H38 almost exclusively populates the gauche+ rotamer (ca. 98% population), whereas its protonation triggers complete conversion to the trans (48%) and gauche- (52%) rotamers without impacting its backbone dihedrals (Figure 3D).
Figure 3. Protonation of H38 leads to a redistribution of side-chain χ1 torsion angles.
χ1 rotamer populations (gauche+, trans, gauche-) derived from the 5-μs MD simulations of the H38-neutral (A) or H38-protonated (B) states of the C9CARD. Residues with empty data points correspond to Ala and Gly residues. (C) Population difference plot (protonated minus neutral), where orange (blue) values are positive (negative) and correspond to an enriched (depleted) rotamer in the H38-protonated state. (D) Rotamer distributions over the trajectories for H38-neutral (blue) and H38-protonated (orange) for the indicated side chains. (E, F) Two-dimensional surfaces showing the increased conformational heterogeneity upon H38 protonation for the side chains of H38 and R65.
The origin of this rotameric change likely involves the helix dipole at the N-terminus of helix-3, where H38 is located as an N-cap residue. In its neutral form, the imidazole ring of H38 points inward toward the dipole of helix-3, perhaps stabilizing the partial positive charge of the helix dipole. Upon protonation of the imidazole ring, however, the positive charges would experience an electrostatic clash; thus, the trans and gauche- rotameric states of H38 position the imidazole ring away and nearly perpendicular to the helix dipole, thereby minimizing a direct clash. Furthermore, our measured pKa value of 6.03 for H38 agrees with studies in model peptides where a His residue in an N-cap position yields a pKa of 6.1 as compared to 7.4 in a C-cap position70–72. In addition, the protonation of a His residue in an N-cap position significantly destabilizes helical peptides73, which agrees with our thermal melting data above.
Cryo-EM structures of the C9CARD filament and its H38R variant
To examine the structural properties of the C9CARD filament in more detail, we determined high-resolution structures of the WT and H38R CARD filaments with cryo-EM (Figure 4). For the WT filament, we observed bundle formation in which multiple filaments clustered together. We were able to overcome the bundles in our cryo-EM data analysis, eventually obtaining a 3.2-Å map. By contrast, the H38R filaments were long and straight, without significant bundle formation, leading to determination of a slightly lower resolution 3.4-Å model. Our cryo-EM derived models of the C9CARD subunit are highly similar to the available crystal structures of the C9CARD, with backbone root-mean-square deviation values near 0.4 Å (Figure 4), showing that the overall tertiary structure is preserved within the filament. Both filaments display C2 symmetry with left-handed, two-start helical assembly consisting of approximately five subunits per turn. The H38R filament has a twist angle of −67.2° and an axial rise of 9.1 Å per subunit. The inner and outer diameters of the WT and H38R filaments are respectively 1.7 and 9.2 and 1.5 and 9 nm (Figure 4A, 4B).
Figure 4. Cryo-EM structures of the C9CARD filament and its H38R variant.
(A) Side view of the cryo-EM structure of the C9CARD filament, including a rotated view down the filament that depicts the inner and outer diameters. (B) The same as in A but for the H38R filament. Zoomed-in regions that correspond to the type-1 (C), type-3 (D), and type-2 (E) interfaces are shown along with the corresponding interface area in square Å. (F) A type-1 interface triple mutant introduced into the H38R variant (R7E/R11E/R56E) is prevents filament formation. The Csat could not be determined, because the triple mutant did not aggregate in this assay.
Similar to other DDF filaments, the C9CARD filament involves three major asymmetric interfaces with opposing interacting surfaces designated as a and b (Figure 4C, 4D, 4E). The WT and H38R filaments share similar interfaces, with the type-1 and −2 interfaces mediating intra-strand interactions between the helical turns, whereas the type-3 interface forms inter-strand interactions in the helical strand direction. In the H38R filament, the type-2 and type-3 interfaces bury slightly more area than the in the WT filament. H38 is located in the type-2 interface, and thus its mutation to Arg increases the interaction surface area. The type-1 interface is the most extensive due to electrostatic complementarity, covering a total buried surface area of 376 Å2 and 384 Å2 in the WT and H38R filaments (Figure 4C), and thus likely contributes the most to the binding energy required for filament formation. This interface mediates interaction between residues in the α2 and α3 helices (e.g., E33, S31, D27, Q24) of one subunit with residues in the α1 and α4 helices (e.g., R52, R56, R13, R11, R7) of the neighboring subunit. Within a distance of 4 Å, there are a total of six hydrogen bonds and four salt bridges contributing to this interface. The type-3 interface (Figure 4D) buries 132 Å2 and 234 Å2 of surface area, respectively, contains H38 as well as salt bridges between the guanidinium group of arginine and side chains of glutamate and aspartate. In total, there are four salt bridges and three hydrogen bonds that contribute to this interface. The type-3 interface mediates interaction between residues in the α2-α3 loop and the α3 helix of one subunit with the residues in the α4 helix and α1-α2 loop of the neighboring subunit. The type-2 interface, with a total buried surface area of 101 Å2 and 174 Å2, respectively (Figure 4E), is the least extensive among all three interfaces. It constitutes only two hydrogen bonds between residues in the α5-α6 loop and α6 helix of one chain to the α1 helix of the neighboring chain.
To test the cryo-EM model of the C9CARD filament, we generated a triple-mutant in which the mutations R7E, R11E, R56E were introduced to the H38R variant (Figure 4F). These charge-reversing mutations were designed to disrupt interactions across the type-1 interface of the C9CARD filament. We purified the H38R/triple-mutant and measured its solubility under filament-forming conditions at pH 5.5. However, we were not able to induce aggregates, suggesting that it is unable to form filaments even at high protein concentrations above 3 mM. Thus, the structure-based mutations that we introduced into the H38R variant raised its Csat from ca. 50 μM to over 3 mM, corresponding to an increase of more than 60-fold. Finally, we compared the molecular interactions within the C9CARD filament to those formed with the Apaf-1 CARD (ApafCARD) in the apoptosome. The type-1b interface of the filament involves residues in the α1 and α4 helices, which form the primary interaction surface for the ApafCARD (PDB: 3ygs), suggesting that the C9CARD filament would be unable to associate with ApafCARD or the apoptosome.
Comparing CARDs from the paralogs C9 and C1
Given the observation that the C9CARD self-assembles into filaments, and with access to its high-resolution structure, we next compared the sequence and structure of C9CARD to its paralog C174,75. C1 mediates homotypic CARD-CARD interactions and self-assembles into filaments during the innate immune response76,77. Structural alignment of the helices in C1CARD (PDB: 5fna) and C9CARD (PDB: 4hrw) yields a backbone root-mean-square deviation of 1.6 Å, indicating highly similar structures. We analyzed the per-residue sequence conservation among C1 and C9 orthologs (Figure 5A), from which it is evident that buried residues have a higher degree of sequence conservation, as expected given the structural restraints imposed by the three-dimensional fold of the CARD. Indeed, when we quantified the relative solvent accessible surface area (rSASA), we observed that buried residues are more likely to be conserved in both C9 and C1 orthologs (Figure 5B, 5C). This result is consistent with previous work that quantified the rate of sequence changes in surface residues versus buried residues78,79.
Figure 5. Comparison of C9CARD and C1CARD sequences.
(A) ConSurfDB81-derived sequence identity among C9 orthologs mapped onto the structure of the C9CARD (PDB: 4rhw). The degree of conservation is shown with the color bar. Amino-acid side chains show that buried residues appear more conserved than those on the surface. (B) 2D histogram showing the per-residue relative solvent accessible surface area (rSASA) versus the ConSurf81 score for both the C9CARD and C1CARD. (C) Box-plot representation of the data in panel B, plotted here as a function of the rSASA range in 25%-increment steps between 0–100%. The number of residues in each bin is listed below. The boxes include data points between the first and third quartiles, with the whiskers extending to 1.5-fold the interquartile range. (D) Pairwise sequence identity between C1CARD and C9CARD computed for all residues in the alignment (All), only buried residues (pink, rSASA < 25%), only surface residues (teal, rSASA ≥ 25%), or only surface residues involved in the type-1 filament interface (purple). The number of residues in each is shown below. A box plot of the distribution of pairwise sequence identities between randomly sampled surface residues (n = 9) over 10,000 simulations is shown in yellow.
A global pairwise sequence alignment of the two CARDs reveals only 20% sequence identity (Figure 5D). When considering only buried (surface) residues, the pairwise sequence identity only slightly increases (decreases) (Figure 5D), indicating that the sequence differences are widespread. However, detailed inspection of the C1CARD and C9CARD surfaces reveals additional insight into their evolutionary relationships. When considering only the surface residues that comprise the largest type-1 interface in the C1CARD filament51 (PDB: 5fna, R10, K11, R15, N23, D27, E28, Q31, D52, R55), we find that the C9CARD and C1CARD exhibit 56% identity at these nine positions (Figure 5D). To test the significance of this value, we randomly sampled surface residues (n = 9) from the C1CARD 10,000 times and quantified the pairwise sequence identity to C9CARD at these sites. This random-sampling approach yielded a mean sequence identity of 18 ± 12% among surface residues, which corresponds to a Z-score of 3.2 and an empirical p value of 1 × 10−4, indicating that the type-1 interface residues on the surface are statistically more conserved than random chance. This observation is surprising because surface residues typically evolve at a four-fold faster rate than buried residues in the hydrophobic core of proteins78,79. On the other hand, conserved surface residues can signify shared and functionally relevant protein-protein interaction sites; yet the C1CARD and C9CARD do not share any known DDF interactors80. An alternative explanation is that the conserved surface residues are involved in a homo-oligomeric interface, like the type-1 filament interface of these filaments.
Discussion
CARDs are protein-protein interaction modules that function in apoptotic and inflammatory signaling pathways39,41,82. Even though CARD domains have high structural similarity, their activation mechanisms and assembly architectures vary and range from monomers, dimers, soluble oligomers, or insoluble filaments41. The C9CARD has served as a model system for structural and biophysical studies of CARDs, with multiple high-resolution structures available as well as insight into its oligomeric architecture that forms upon binding to Apaf-1CARD in the apoptosome 10,15,16. Here, we found that the C9CARD can access yet another structural form and polymerizes into filaments in vitro at physiological pH and salt concentrations. The propensity to form filaments was enhanced under low-salt or acidic conditions, suggesting a significant role for electrostatic interactions in driving filament formation. Charge-altering mutations of the lone histidine residue to introduce a positive (H38R) or negative (H38D) charge, or to remove the charge at this site altogether (H38N), dramatically modulated the self-assembly of the C9CARD, indicating that interactions involving H38 contribute to filament formation.
Using NMR spectroscopy, we determined the pKa of H38 to be 6.03 ± 0.04, confirming that the side chain is predominantly protonated under acidic conditions at pH 5.5 where the C9CARD is highly filamentous. We further employed an integrative biophysical and structural approach to understand the destabilizing effect of H38 protonation or the H38R mutation, identifying an electrostatic clash with the partial positive charge from the helix dipole. We used cryo-electron microscopy to determine 3.2- and 3.4-Å structures of the WT C9CARD and H38R filaments. Like other DDFs filament structures, C9CARD shows extensive electrostatic interactions between the CARD subunits within the filament at the type-1 interface, while H38 is involved in the type-3 interface and the H38R increases the size of this interface.
The paralogous C1, which shares the same domain architecture with C9, is known to form filaments during its activation51. Paralogs arise through gene duplication and often retain structural similarity; however, functional specialization driven by evolutionary pressures can lead to substantial sequence divergence83–85. Indeed, at the sequence level, C1CARD and C9CARD have highly diverged, with only 20% identity between the two domains. Nonetheless, we found that the surface residues that comprise the type-1 filament interface are over 50% identical between the two paralogs, which far exceeds expectations from random sampling of the solvent-accessible surface. This observation suggests that residues at the type-1 interface may have been more preserved after functional divergence.
In context of full-length C9, filament formation by the CARD would lead to an increase in the local effective concentration of the attached protease domain that may prime it for catalytic activity. Activation of the protease domain requires dimerization, which very weakly dimerizes (Kd > 10 mM) in the absence of substrate20. For four C9 molecules that were tethered to the apoptosome, the local effective concentration (Ceff) was determined to be 0.5 mM20, which is far below the dimerization Kd and insufficient to trigger activation in the absence of substrate. On the other hand, in the filamentous state, the Ceff of the protease domain is expected to be significantly higher due to the larger number of molecules involved in the filament, which could lead to auto-activation of C9 in an analogous way to C151.
Our experiments in this study were performed in vitro with purified components, and thus it remains unclear if the C9CARD self-assembles into filaments in vivo. However, the relatively high Csat concentration of the C9CARD at physiological pH (ca. 150 μM), which was obtained in the absence of salt, suggests that a “priming” event may be required to nucleate C9CARD filaments in vivo. Given that the concentration of C9 is expected to be in the nanomolar range in human cells86, filament formation would require clustering of C9 molecules to reach the significantly higher Ceff. As mentioned above, in the case of C9 binding to the apoptosome, the Ceff of the protease domain approaches 500 μM, despite its tethering via a long and disordered linker 20. The Ceff of the C9CARD on the apoptosome, by definition, would be significantly larger due to the smaller volume occupied by the four C9 molecules; however, the C9 residues involved in the filamentous interface would be occupied by interactions with Apaf-1CARD. Thus, filaments involving C9CARD would only be possible upon dissociation from Apaf-1CARD and clustering, or upon a nucleation or priming event that presents available and exposed C9CARD molecules for further polymerization.
Interestingly, Borgeaud and colleagues87 recently reported that, in cells, the apoptosome forms large, transient assemblies or foci that depend on the Apaf-1CARD. The apoptosome foci did not form in cells that were devoid of C9, suggesting a potential link between foci formation and CARD-CARD interactions involving Apaf-1 and C9 87. Similarly, the CARD from C2 was recently reported to be necessary for liquid-liquid phase separation in the presence of ubiquitin59, further highlighting the range of assemblies that are accessible to caspase CARDs in cells. While the physiological relevance of the C9CARD filament remains to be tested, we
In summary, we identified a helical filament that is formed by the C9CARD and investigated the biophysical properties that drive filament formation. We identified a histidine residue (H38) whose protonation or Arg-mutation stimulates filament assembly, thus functioning as a pH-sensitive switch that regulates CARD polymerization. Indeed, removing the charge at this position via the H38N mutation generated a highly soluble protein whose Csat could not be determined. Cryo-EM structures of the wild-type and H38R C9CARD filaments reveal a similar overall architecture to other CARD filaments and expand the overall catalog of known DDF filaments. Our identification of a natural, pH-responsive protein filament may be relevant for the de-novo design of protein filaments: Shen and colleagues have recently described an approach to design pH-responsive protein filaments that leverage His protonation88. Taken together, our findings suggest that C9CARD polymerization is finely tuned by local physicochemical cues, particularly pH, through a single histidine residue that modulates charge at a structurally sensitive site.
Methods
Protein expression and purification
DNA encoding for human caspase-9 (UniProt ID: P55211) was synthesized and codon optimized for E. coli expression by GenScript20. The gene was then sub-cloned into a pET-29b(+) expression vector that contained an N-terminal hexahistidine-tag followed by small ubiquitin-like modifier (His-SUMO) solubility tag. Two fragments of caspase-9 were derived from the full-length plasmid via mutagenesis: the CARD domain (residues 1–99) and the CARD+linker (residues 1–138)20. All mutagenesis, including point mutants of H38 (vide infra) and elsewhere in the CARD, was performed by GenScript. All of the caspase-9 expression constructs contain a Ser-Gly linker that separates His-SUMO from Met1 of the CARD domain. This was found to be necessary to enable complete cleavage of the His-SUMO tag by the Ulp1R3 SUMO protease20, likely for steric reasons due to the burial of Met1 in the structure of the CARD.
For recombinant protein expression and purification, we followed previously established protocols for C9CARD+linker and C9 (C287A) 20. All variants were expressed and purified similarly. For the production of 15N-labeled or 13C,15N-labeled protein, M9 minimal medium was used with 1 g/L of 15NH4Cl and 6 g/L of D-glucose or 1 g/L of NH4Cl and 2 g/L of uniformly 13C-labeled D-glucose, respectively. Protein purification proceeded as outlined above.
NMR Spectroscopy
All NMR samples were prepared in in 5-mm NMR tubes with 5% 2H2O added for the lock. To obtain resonance assignments of the C9CARD, a 13C,15N-labelled sample of C9CARD was prepared at a protein concentration of 1.4 mM in 25 mM MES at pH 6.5 with 50 mM NaCl. Backbone (1HN, 1Hα, 15N, 13CO, 13Cα) and side-chain (aliphatic 13C/1H, Arg 15Nε/1Hε) resonances were assigned based on three-dimensional (3D) HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, C(CO)NH, H(CCO)NH spectra89 recorded at 20 °C on a Bruker Avance-III 700-MHz spectrometer equipped with a cryogenically cooled, 5-mm TCI probe. Non-uniform sampling was employed in which the data sampling density in the indirect dimensions ranged from 10–25% and was based on a random sampling schedule. Spectral reconstruction was performed using SMILE90. All spectra were processed using NMRPipe91 and analyzed using NMRFAM-Sparky92. For secondary structure determination, the assigned backbone and 13Cβ chemical shifts were analyzed using TALOS-N93.
15N longitudinal (T1) and transverse rotating-frame (T1ρ) spin relaxation experiments94 were collected on 15N-labeled C9CARD at a protein concentration of 0.84 mM in 25 mM HEPES, 50 mM NaCl, 2 mM DTT at pH 6.5 with the temperature set to 25 °C. Data were recorded on a 600-MHz Bruker Avance Neo NMR spectrometer with a room-temperature probe. The pulse sequences employed HSQC-based detection with sensitivity enhancement95. Magnetization was sampled at delay times of 0.01, 0.1, 0.25, 0.38, 0.5 (x2), 0.62, and 0.75 seconds, with a duplicated value at 0.5 seconds for error analysis. In the T1ρ experiment, a 2-kHz 15N spin-lock field was applied to suppress chemical exchange during the transverse relaxation delay time (T), with 1H inversion pulses applied at T/4 and 3T/4 intervals to suppress cross-correlated relaxation between 1H-15N dipolar coupling and 15N chemical shift anisotropy 96 Magnetization was sampled at delay times of 5, 15, 30 (x2), 50, 75, 100, and 150 ms, with the 30-ms time point duplicated for error analysis. In both experiments, 8 scans were collected per FID with an inter-scan delay of 3 seconds. The 15N and 1H spectral widths were 1095 and 9615 Hz with 50* and 615* complex points collected in each dimension, respectively corresponding to acquisition times of 45.6 and 64 ms. The 15N spin relaxation datasets were processed with NMRPipe and NMRFAM-Sparky was used to pick peaks for subsequent lineshape fitting in FuDA97.
For the H38 pKa determination, a 13C,15N-labeled C9CARD sample was prepared, and the pH was varied in 0.5-unit steps between 4 and 9.5 via the addition of concentrated HCl or NaOH aliquots. For each pH value, a 2D 1H-13C HSQC spectrum was recorded, and we focused on the His 13Cε chemical shift given that this site is sensitive to protonation of the imidazole ring but not impacted by the relative populations of the two different neutral tautomers 98–101. The variation in the 13Cε chemical shift of H38 was fit to the Henderson-Hasselbalch equation:
Where is the observed chemical shift, the measured chemical shifts at pH 4, and is the difference in chemical shift between the neutral and protonated forms. Least-squares fitting was performed in Python using the lmfit package 102, and the error was estimated from a standard bootstrap with 1,000 iterations.
HydroNMR simulation
The C9CARD crystal structure (4rhw, chain E) was supplied as input to the HydroNMR103 software program, which was used via the NMRbox resource104. In the simulation, the temperature was set to 25 °C to match the 15N relaxation experiments, with the solvent viscosity adjusted to 1 cPa. All other parameters, including the minimum and maximum radii of beads in the shell, were left at default values. The simulations assumed an N-H bond-length of 1.02 Å and a 15N chemical shift anisotropy of −160 ppm. The simulated rotational diffusion tensor of the C9CARD yields values for Dxx, Dyy, and Dzz of 2.86, 2.89, and 3.39 × 107 s−1, respectively, yielding an isotropic rotational correlation time of Diso = 1/[6Tr(D)] = 5.47 × 10−9 s, where Tr(D) corresponds to the trace of the 3×3 rotational diffusion matrix, or 1/3 (Dxx + Dyy + Dzz). However, the rotational diffusion of C9CARD appears approximately axially symmetric, with the anisotropic rotational diffusion values Dx = 2.90 × 107 s−1, Dy = 2.79 × 107 s−1, and Dz 3.43 × 107 s−1 corresponding to values of 2Dz / (Dx + Dy) = 1.20 and Dx/Dy = 1.04.
Differential Scanning Fluorimetry
To measure the melting temperature of C9CARD variants, we mixed protein sample and SYPRO Orange dye (Thermo Fisher Scientific) in a 96-well plate (Bio-Rad) to a total volume of 25 μL per well. All conditions contained a protein concentration of 30 μM in 25 mM MES and 2 mM DTT at pH 5.5 or 7. SYPRO orange dye was added to each well in 1:2500 dilution, and the plate was then sealed. Fluorescence was measured in a Bio-Rad CFX96 RT-PCR instrument with the temperature increased from 20 °C to 95 °C in 0.5-°C increments every 30 seconds. The melting temperature was calculated from the first derivative of fluorescence versus temperature. All measurements were performed in triplicates, and the reported values are the mean and one standard deviation, normalized to the maximum and minimum values of each run.
Negative-stain Electron Microscopy
A carbon-coated copper grid (400-mesh) (Science Services, Germany) was glow-discharged using a PELCO easiGlow™ Glow Discharge Cleaning System (Ted Pella Inc., USA)) to make it hydrophilic for homogenous sample distribution. 10 μL of purified C9CARD (25 mM HEPES, 200 mM NaCl, 0.5 mM EDTA, 2 mM TCEP, pH 7.5) was adsorbed onto the glow-discharged grid and allowed to settle for 1 minute. The remaining sample was carefully removed with filter paper, and immediately 10 μL of a 1% (w/v) uranyl acetate staining solution was added. The uranyl acetate solution was allowed to settle for 1 minute and the excess solution was removed using filter paper. The sample was air dried for few minutes before putting inside the microscope. Sample visualization was done on a Tecnai G2 FEI (Thermo Fisher Scientific Inc., USA) microscope equipped with an Ultrascan 1000 CCD camera (Gatan AMETEK, Germany) operating at an acceleration voltage of 120 kV.
Structure-based pKa prediction
PDB files were uploaded to the PDB2PQR webserver that assigns titration states with version 3.6.1 of PROPKA67. The pH of the calculation was set to 7.0 and the default forcefield was used. Steric clashes were removed with the debump algorithm inside PDB2PQR that optimizes inter-atomic distances that fall below defined threshold values of 1.0 Å for hydrogen-hydrogen, 1.5 Å for hydrogen-heavy atom, and 2.0 Å for heavy atom-heavy atom collisions. Hydrogen bond networks were optimized by PDB2PQR by enabling the flipping of His, Asn, and Gln side chains, the rotation of side-chain hydrogen atoms on Ser, Thr, Tyr, and Cys residues, and placement of side-chain hydrogen atoms on His, Asp, and Glu.
Molecular Dynamics Simulations
We performed all-atom molecular dynamics simulations with the GROMACS105 simulation package using the AMBER99SB-ILDN force field106. We selected the highest-resolution crystal structure of the C9CARD (PDB: 4rhw) and extracted chain E from the PDB file. The system was solvated in a rhombic dodecahedron of TIP4P-EW107 water molecules with a minimal distance of 10 Å between the protein and the box edge, and then energy minimized using the steepest descent algorithm to remove any steric clashes, with the maximum force set to 1000 kJ mol−1 nm-1. Following minimization, the system was equilibrated in two steps: NVT equilibration at 300 K for 100 ps, using the v-rescale thermostat108, and NPT equilibration at 300 K and 1 bar for an additional 100 ps, with Berendsen pressure-coupling109. During equilibration, all protein heavy atoms were restrained to their initial positions. Production MD simulations were carried out in the NPT ensemble at 300 K and 1 bar using periodic boundary conditions. The particle mesh Ewald method110 was employed for long-range electrostatic interactions beyond 1.0 nm, and we used a 1.0 nm cutoff for van der Waals interactions. The simulation time step was set to 2 fs, and coordinates were saved every 10 ps. The temperature was maintained at 300 K using the v-rescale thermostat, while pressure was controlled using the Parrinello-Rahman barostat111. All simulations were performed on a single node utilizing 32 CPUs or one GPU. For each system, we discarded the first 50-ns of production MD simulations and quantitatively analyzed the subsequent 5 μs. We performed replicate simulations by extracting two random conformations from the first 50-ns of production MD, with a different seed assigned for the random initial velocities that were assigned from a Boltzmann distribution. This yielded a total of three replicates for each system, totaling 15 microseconds of production MD per system. In the first simulation, H38 was in its neutral state and a proton was placed on the ND1 position. In the second simulation H38 contained two protons at the ND1 and NE1 positions, creating the cationic form. Overall charge neutrality was maintained in both simulations through the addition of counter ions.
Cryo-Electron Microscopy
The grids were prepared and vitrified at the Cryo-Electron Microscopy Platform (CEMP) of Helmholtz Munich. For cryo-EM grid preparation, 4.5 μL of the C9CARD sample was applied to a glow-discharged 200 mesh Quantifoil R2/1 grid, blotted for 4 s with force 4 in a Vitrobot Mark III (Thermo Fisher) at 100% humidity and 4 °C. Grids were plunge frozen in liquid ethane-propane mixture, cooled by liquid nitrogen. Cryo-EM data acquisition was performed with a 300-kV, FEI Titan Krios transmission electron microscope (Thermo Fisher) with EPU software. Movie frames were recorded at a magnification of 130,000x using a Falcon4i direct electron detector camera. The total electron dose of about 55 electrons per Å2 was distributed over 30 frames at two different pixel sizes of 0.76 Å and 0.95 Å. The two collected datasets were processed separately and merged after extracting them to respective box sizes corresponding to a pixel size of 0.95 Å. Movies were recorded in a defocus range of −0.75 to −2.5 μm. Data processing was performed using the CryoSparc v4.4.1 helical reconstruction pipeline112. The final resolution between half maps and map versus model was determined after post-processing in RELION 113, using the Gold Standard Fourier Shell Correlation (GS-FSC) threshold value of 0.143 and 0.5, respectively. Sharpening was done with an ad-hoc B-factor of 90 Å2, which was selected based on the initial 3D refinement observations. Interfacial residues and surface area calculations were performed using PDBePISA (https://www.ebi.ac.uk/pdbe/pisa/). The final structural rendering was completed using UCSF Chimera (20) and UCSF ChimeraX (21).
Pairwise sequence alignments
The C1CARD (residues 1–96) and C9CARD (residues 1–96) were subjected to a pairwise sequence alignment with the EMBOSS Needle webserver 114. This program performs a global sequence alignment using the Needleman-Wunsch algorithm115 and uses a default gap opening penalty of −10, a gap extension penalty of −0.5, with the alignment scored using the BLOSUM62 substitution matrix. This produced an alignment with 26 matches and 12 gaps, corresponding to a pairwise sequence identity of 27.1%.
However, the default parameters in EMBOSS Needle yielded a relatively large number of gaps (12) relative to the lengths of the C1CARD and C9CARD sequences (96 residues), as well as the overall structural similarity of the two domains (< 2 Å RMSD), prompted us to revisit the pairwise alignment. Based on previous work by Elofsson 116, we modified the gap opening (−15) and gap extension penalties (−1), which were reported to produce better global alignments with the BLOSUM62 substitution matrix. Indeed, these modifications introduced only two gaps in the alignment of C9CARD and C1CARD and produced a pairwise sequence identity of 19.8%. We implemented this in BioPython 117 version 1.85 and could produce highly similar alignments in the online EMBOSS Needle webserver when the corresponding parameters were updated (Gap Open = 15, End Gap Open = 15, End Gap = True, Gap Extend = 1, End Gap Extend = 1). Thus, we used these parameters in BioPython for the pairwise sequence alignment. For random sampling, we randomly selected n = 9 residues 10,000 times from the set of all surface residues (defined below), and computed the identity at these sites in the alignment. The mean and standard deviation of the percent identity values were then computed an compared to the observed value of 56%.
Relative solvent accessible surface area
We used DSSP118 version 4.4.7 to calculate the relative solvent accessible surface area (rSASA) for each residue in a PDB file. The BioPython 117 DSSP wrapper was used, and we then parsed the results into an in-house Python script for downstream analysis. We supplied the PDB files 4rhw/chain E (C9CARD) and 5fna/chain A (C1CARD) for these calculations. Because the PDB file 5fna only contains structural data for residues 2–86 of the C1CARD, including an incomplete helix-6 that may produce non-realistic rSASA values, we also ran DSSP on the corresponding AlphaFold2119 structural model of the C1CARD residues 1–96 that we obtained from the AlphaFold Database120 without further modification. The results presented include values derived from the AlphaFold2 model. We used a threshold of 25%, as used previously121, to define surface from buried residues. The sequence identity of surface and buried residues was then determined from their positions in the global pairwise sequence alignment (described above).
ConSurf conservation scores
We extracted ConSurf conservation scores from the ConSurf-DB81 for PDB entries 4rhw, chain E (C9) and 5fna (C1). On the webserver, the reported grades (1–9) are derived from the raw ConSurf scores, with negative scores corresponding to more conserved positions. The assignment of grades can be extracted from the results summary (e.g. https://consurfdb.tau.ac.il/DB_NEW/4RHW/E/4RHW_E_consurf_grades.txt), and we report both values for ease of comparison to the webserver. Raw ConSurf scores for PDB 5fna are reported for residues 2–86, as these residues that are present in the PDB file.
C9 orthologs
To examine the variation in residue type at this position of the CARD across different C9 orthologs, we extracted 182 caspase-9 sequences from the CaspBase75 database. We then further supplemented this dataset with an HHblits122 search that returned over 500 sequence hits, which were redundancy reduced with MMseqs2123 to identify clusters with maximum pairwise identity of 90% (319 clusters).
Supplementary Material
Acknowledgements
We thank Prof. Lewis E. Kay (University of Toronto) for his support and insightful discussions. This study made use of NMRbox: National Center for Biomolecular NMR Data Processing and Analysis, a Biomedical Technology Research Resource (BTRR), which is supported by NIH grant P41GM111135 (NIGMS). S.R. was trained within the frame of the PhD program BioMolStruct and received funding from the Marietta Blau-Stipendium of the Austrian Agency for Education and Internationalization. We thank the Helmholtz Munich Digital Transformation and IT Department (DigIT) team for support of computational resources. T.R.A. acknowledges funding from the Initiative and Networking Fund of the Helmholtz Association (Helmholtz Investigator Grant VH-NG-20-14).
Footnotes
Competing Interest
The authors declare no competing interests.
References
- 1.Taylor R.C., Cullen S.P., and Martin S.J. (2008). Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol S, 231–241. 10.1038/nrm2312. [DOI] [PubMed] [Google Scholar]
- 2.Strasser A., O’Connor L., and Dixit V.M. (2000). Apoptosis Signaling. Annu Rev Biochem cS, 217–245. 10.1146/annurev.biochem.69.1.217. [DOI] [PubMed] [Google Scholar]
- 3.Hengartner M.O. (2000). The biochemistry of apoptosis. Nature 407, 770–776. 10.1038/35037710. [DOI] [PubMed] [Google Scholar]
- 4.Mattson M.P. (2000). Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1, 120–130. 10.1038/35040009. [DOI] [PubMed] [Google Scholar]
- 5.Brown J.M., and Attardi L.D. (2005). The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5, 231–237. 10.1038/nrc1560. [DOI] [PubMed] [Google Scholar]
- 6.Carneiro B.A., and El-Deiry W.S. (2020). Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17, 395–417. 10.1038/s41571-020-0341-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Johnstone R.W., Ruefli A.A., and Lowe S.W. (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153–164. 10.1016/s0092-8674(02)00625-6. [DOI] [PubMed] [Google Scholar]
- 8.Kesavardhana S., Malireddi R.K.S., and Kanneganti T.D. (2020). Caspases in Cell Death, Inflammation, and Pyroptosis. Annu Rev Immunol 38, 567–595. 10.1146/ANNUREV-IMMUNOL-073119-095439,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nadendla E.K., Tweedell R.E., Kasof G., and Kanneganti T.D. (2025). Caspases: structural and molecular mechanisms and functions in cell death, innate immunity, and disease. Cell Discov 11. 10.1038/S41421-025-00791-3,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rodriguez J., and Lazebnik Y. (1999). Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev 13, 3179–3184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Salvesen G.S., and Dixit V.M. (1999). Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A Sc, 10964–10967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Julien O., and Wells J.A. (2017). Caspases and their substrates. Preprint at Nature Publishing Group, 10.1038/cdd.2017.44 https://doi.org/10.1038/cdd.2017.44. [DOI] [Google Scholar]
- 13.Shi Y. (2002). Mechanisms of Caspase Activation and Inhibition during Apoptosis. Mol Cell S, 459–470. 10.1016/S1097-2765(02)00482-3. [DOI] [PubMed] [Google Scholar]
- 14.Soni I. V., and Hardy J.A. (2021). Caspase-9 Activation of Procaspase-3 but Not Procaspase-6 Is Based on the Local Context of Cleavage Site Motifs and on Sequence. Biochemistry c0, 2824–2835. 10.1021/ACS.BIOCHEM.1C00459,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Qin H., Srinivasula S.M., Wu G., Fernandes-Alnemri T., Alnemri E.S., and Shi Y. (1999). Structural basis of procaspase-9 recruitment by the apoptotic protease- activating factor 1. Nature 3SS, 549–557. 10.1038/21124. [DOI] [PubMed] [Google Scholar]
- 16.Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell S1, 479–489. 10.1016/S0092-8674(00)80434-1. [DOI] [PubMed] [Google Scholar]
- 17.Anson F., Thayumanavan S., and Hardy J.A. (2021). Exogenous Introduction of Initiator and Executioner Caspases Results in Different Apoptotic Outcomes. JACS Au 1, 1240–1256. 10.1021/JACSAU.1C00261/SUPPL_FILE/AU1C00261_SI_001.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Araya L.E., Soni I. V., Hardy J.A., and Julien O. (2021). Deorphanizing Caspase-3 and Caspase-9 Substrates In and Out of Apoptosis with Deep Substrate Profiling. ACS Chem Biol 1c, 2280–2296. 10.1021/ACSCHEMBIO.1C00456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., and Salvesen G.S. (2001). Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci U S A S8, 14250–14255. 10.1073/PNAS.231465798,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sever A.I.M., Reid Alderson T., Rennella E., Aramini J.M., Liu Z.H., Harkness R.W., and Kay L.E. (2023). Activation of caspase-9 on the apoptosome as studied by methyl-TROSY NMR. Proc Natl Acad Sci U S A 120. 10.1073/PNAS.2310944120,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mashima T., Rosier B.J.H.M., Oohora K., de Greef T.F.A., Hayashi T., and Brunsveld L. (2021). Dynamic Protease Activation on a Multimeric Synthetic Protein Scaffold via Adaptable DNA-Based Recruitment Domains. Angewandte Chemie - International Edition c0, 11262–11266. 10.1002/ANIE.202102160,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Di Stasi A., Tey S.-K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., Straathof K., Liu E., Durett A.G., Grilley B., et al. (2011). Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy. New England Journal of Medicine 3c5, 1673–1683. 10.1056/NEJMOA1106152/SUPPL_FILE/NEJMOA1106152_DISCLOSURES.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Allan L.A., Morrice N., Brady S., Magee G., Pathak S., and Clarke P.R. (2003). Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5, 647–654. 10.1038/ncb1005. [DOI] [PubMed] [Google Scholar]
- 24.Allan L.A., and Clarke P.R. (2007). Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 2c, 301–310. 10.1016/J.MOLCEL.2007.03.019. [DOI] [PubMed] [Google Scholar]
- 25.Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., and Reed J.C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science (1979) 282, 1318–1321. 10.1126/SCIENCE.282.5392.1318,. [DOI] [PubMed] [Google Scholar]
- 26.Serrano B.P., Szydlo H.S., Alfandari D., and Hardy J.A. (2017). Active site-adjacent phosphorylation at Tyr-397 by c-Abl kinase inactivates caspase-9. Journal of Biological Chemistry 2S2, 21352–21365. 10.1074/jbc.M117.811976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Serrano B.P., and Hardy J.A. (2018). Phosphorylation by protein kinase A disassembles the caspase-9 core. Cell Death Differ 25, 1025–1039. 10.1038/S41418-017-0052-9,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ge J., Wang Y., Li X., Lu Q., Yu H., Liu H., Ma K., Deng X., Luo Z.Q., Liu X., et al. (2024). Phosphorylation of caspases by a bacterial kinase inhibits host programmed cell death. Nat Commun 15, 8464. 10.1038/S41467-024-52817-1,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Huber K.L., and Hardy J.A. (2012). Mechanism of zinc-mediated inhibition of caspase-9. Protein Science 21, 1056–1065. 10.1002/PRO.2090,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Huber K.L., Ghosh S., and Hardy J.A. (2012). Inhibition of caspase-9 by stabilized peptides targeting the dimerization interface. Biopolymers S8, 451–465. 10.1002/BIP.22080,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Maciag J.J., Mackenzie S.H., Tucker M.B., Schipper J.L., Swartz P., and Clark A.C. (2016). Tunable allosteric library of caspase-3 identifies coupling between conserved water molecules and conformational selection. Proc Natl Acad Sci U S A 113, E6080–E6088. 10.1073/PNAS.1603549113,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Thomas M.E., Grinshpon R., Swartz P., and Clark A.C. (2018). Modifications to a common phosphorylation network provide individualized control in caspases. Journal of Biological Chemistry 2S3, 5447–5461. 10.1074/jbc.RA117.000728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cade C., Swartz P., MacKenzie S.H., and Clark A.C. (2014). Modifying caspase-3 activity by altering allosteric networks. Biochemistry 53, 7582–7595. 10.1021/BI500874K,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Walters J., Schipper J.L., Swartz P., Mattos C., and Clark A.C. (2012). Allosteric modulation of caspase 3 through mutagenesis. Biosci Rep 32, 401–411. 10.1042/BSR20120037,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hardy J.A., Lam J., Nguyen J.T., O’Brien T., and Wells J.A. (2004). Discovery of an allosteric site in the caspases. Proc Natl Acad Sci U S A 101, 12461–12466. 10.1073/PNAS.0404781101,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Hardy J.A., and Wells J.A. (2009). Dissecting an allosteric switch in caspase-7 using chemical and mutational probes. Journal of Biological Chemistry 284, 26063–26069. 10.1074/jbc.M109.001826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Velázquez-Delgado E.M., and Hardy J.A. (2012). Zinc-mediated allosteric inhibition of caspase-6. Journal of Biological Chemistry 287, 36000–36011. 10.1074/JBC.M112.397752,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Clark A.C. (2016). Caspase Allostery and Conformational Selection. Chem Rev 11c, 6666–6706. 10.1021/ACS.CHEMREV.5B00540,. [DOI] [PubMed] [Google Scholar]
- 39.Hyun H.P., Lo Y.C., Lin S.C., Wang L., Jin K.Y., and Wu H. (2007). The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 25, 561–586. 10.1146/ANNUREV.IMMUNOL.25.022106.141656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Zhou W., Kaneko N., Nakagita T., Takeda H., and Masumoto J. (2021). A comprehensive interaction study provides a potential domain interaction network of human death domain superfamily proteins. Cell Death C Differentiation 2021 28:11 28, 2991–3008. 10.1038/s41418-021-00796-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Wu E.J., Kandalkar A.T., Ehrmann J.F., Tong A.B., Zhang J., Cong Q., and Wu H. (2025). A structural atlas of death domain fold proteins reveals their versatile roles in biology and function. Proc Natl Acad Sci U S A 122, e2426986122. 10.1073/PNAS.2426986122/SUPPL_FILE/PNAS.2426986122.SAPP.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Shiozaki E.N., Chai J., and Shi Y. (2002). Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc Natl Acad Sci U S A SS, 4197–4202. 10.1073/pnas.072544399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hu Q., Wu D., Chen W., Yan Z., Yan C., He T., Liang Q., and Shi Y. (2014). Molecular determinants of caspase-9 activation by the Apaf-1 apoptosome. Proc Natl Acad Sci U S A 111, 16254–16261. 10.1073/pnas.1418000111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhou P., Chou J., Olea R.S., Yuan J., and Wagner G. (1999). Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: A structural basis for specific adaptor/caspase interaction. Proc Natl Acad Sci U S A Sc, 11265. 10.1073/PNAS.96.20.11265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Su T.W., Yang C.Y., Kao W.P., Kuo B.J., Lin S.M., Lin J.Y., Lo Y.C., and Lin S.C. (2017). Structural Insights into DD-Fold Assembly and Caspase-9 Activation by the Apaf-1 Apoptosome. Structure 25, 407–420. 10.1016/J.STR.2016.12.019. [DOI] [PubMed] [Google Scholar]
- 46.Ortega-vallbona R., Johansson L., Carpio L.E., Serrano-candelas E., Mahdizadeh S.J., Fearnhead H., Gozalbes R., and Eriksson L.A. (2025). Computational Characterization of the Interaction of CARD Domains in the Apoptosome. Biochemistry c4. 10.1021/ACS.BIOCHEM.4C00583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cheng T.C., Hong C., Akey I. V, Yuan S., and Akey C.W. (2016). A near atomic structure of the active human apoptosome. Elife 5. 10.7554/ELIFE.17755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Li Y., Zhou M., Hu Q., Bai X., Huang W., Scheres S.H.W., and Shi Y. (2017). Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme. Proceedings of the National Academy of Sciences 114, 1542–1547. 10.1073/pnas.1620626114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Huber K.L., Serrano B.P., and Hardy J.A. (2018). Caspase-9 CARD: Core domain interactions require a properly formed active site. Biochemical Journal 475, 1177–1196. 10.1042/BCJ20170913,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wu B., Peisley A., Tetrault D., Li Z., Egelman E.H., Magor K.E., Walz T., Penczek P.A., and Hur S. (2014). Molecular Imprinting as a Signal-Activation Mechanism of the Viral RNA Sensor RIG-I. Mol Cell 55, 511–523. 10.1016/J.MOLCEL.2014.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Lu A., Li Y., Schmidt F.I., Yin Q., Chen S., Fu T.M., Tong A.B., Ploegh H.L., Mao Y., and Wu H. (2016). Molecular basis of caspase-1 polymerization and its inhibition by a novel capping mechanism. Nat Struct Mol Biol 23, 425. 10.1038/NSMB.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Li Y., Fu T.M., Lu A., Witt K., Ruan J., Shen C., and Wu H. (2018). Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1. Proc Natl Acad Sci U S A 115, 10845–10852. 10.1073/PNAS.1810524115/SUPPL_FILE/PNAS.1810524115.SAPP.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Robert Hollingsworth L., David L., Li Y., Griswold A.R., Ruan J., Sharif H., Fontana P., Orth-He E.L., Fu T.M., Bachovchin D.A., et al. (2021). Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes. Nature Communications 2021 12:1 12, 1–13. 10.1038/s41467-020-20320-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Matyszewski M., Zheng W., Lueck J., Antiochos B., Egelman E.H., and Sohn J. (2018). Cryo-EM structure of the NLRC4CARD filament provides insights into how symmetric and asymmetric supramolecular structures drive inflammasome assembly. Journal of Biological Chemistry 2S3, 20240–20248. 10.1074/JBC.RA118.006050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.David L., Li Y., Ma J., Garner E., Zhang X., and Wu H. (2018). Assembly mechanism of the CARMA1–BCL10–MALT1–TRAF6 signalosome. Proc Natl Acad Sci U S A 115, 1499–1504. 10.1073/PNAS.1721967115/SUPPL_FILE/PNAS.1721967115.SM04.AVI. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Schlauderer F., Seeholzer T., Desfosses A., Gehring T., Strauss M., Hopfner K.P., Gutsche I., Krappmann D., and Lammens K. (2018). Molecular architecture and regulation of BCL10-MALT1 filaments. Nature Communications 2018 9:1 S, 1–12. 10.1038/s41467-018-06573-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Gong Q., Robinson K., Xu C., Huynh P.T., Chong K.H.C., Tan E.Y.J., Zhang J., Boo Z.Z., Teo D.E.T., Lay K., et al. (2021). Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8. Nature Communications 2021 12:1 12, 1–15. 10.1038/s41467-020-20319-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.He L., Bardiaux B., Ahmed M., Spehr J., König R., Lünsdorf H., Rand U., Lührs T., and Ritter C. (2016). Structure determination of helical filaments by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A 113, E272–E281. 10.1073/PNAS.1513119113/SUPPL_FILE/PNAS.201513119SI.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ge Y., Zhou L., Fu Y., He L., Chen Y., Li D., Xie Y., Yang J., Wu H., Dai H., et al. (2024). Caspase-2 is a condensate-mediated deubiquitinase in protein quality control. Nat Cell Biol 2c. 10.1038/S41556-024-01522-8,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Fu T.M., Li Y., Lu A., Li Z., Vajjhala P.R., Cruz A.C., Srivastava D.B., DiMaio F., Penczek P.A., Siegel R.M., et al. (2016). Cryo-EM Structure of Caspase-8 Tandem DED Filament Reveals Assembly and Regulation Mechanisms of the Death Inducing Signaling Complex. Mol Cell c4, 236. 10.1016/J.MOLCEL.2016.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Fox J.L., Hughes M.A., Meng X., Sarnowska N.A., Powley I.R., Jukes-Jones R., Dinsdale D., Ragan T.J., Fairall L., Schwabe J.W.R., et al. (2021). Cryo-EM structural analysis of FADD:Caspase-8 complexes defines the catalytic dimer architecture for co-ordinated control of cell fate. Nat Commun 12. 10.1038/S41467-020-20806-9,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Rossi P., Swapna G.V.T., Huang Y.J., Aramini J.M., Anklin C., Conover K., Hamilton K., Xiao R., Acton T.B., Ertekin A., et al. (2010). A microscale protein NMR sample screening pipeline. J Biomol NMR 4c, 11–22. 10.1007/S10858-009-9386-Z,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., and Salvesen G.S. (1999). Caspase-9 can be activated without proteolytic processing. Journal of Biological Chemistry 274, 8359–8362. 10.1074/jbc.274.13.8359. [DOI] [PubMed] [Google Scholar]
- 64.Singer A.U., and Forman-Kay J.D. (1997). pH titration studies of an SH2 domain-phosphopeptide complex: Unusual histidine and phosphate pK(a) values. Protein Science c, 1910–1919. 10.1002/PRO.5560060912,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Hass M.A.S., and Mulder F.A.A. (2015). Contemporary NMR Studies of Protein Electrostatics. Annu Rev Biophys 44, 53–75. 10.1146/ANNUREV-BIOPHYS-083012-130351,. [DOI] [PubMed] [Google Scholar]
- 66.Tollinger M., Crowhurst K.A., Kay L.E., and Forman-Kay J.D. (2003). Site-specific contributions to the pH dependence of protein stability. Proc Natl Acad Sci U S A 100, 4545–4550. 10.1073/PNAS.0736600100,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Olsson M.H.M., SØndergaard C.R., Rostkowski M., and Jensen J.H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical p K a predictions. J Chem Theory Comput 7, 525–537. 10.1021/CT100578Z/SUPPL_FILE/CT100578Z_SI_001.PDF. [DOI] [PubMed] [Google Scholar]
- 68.Schymkowitz J., Borg J., Stricher F., Nys R., Rousseau F., and Serrano L. (2005). The FoldX web server: an online force field. Nucleic Acids Res 33, W382. 10.1093/NAR/GKI387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zhou Y., Pan Q., Pires D.E.V., Rodrigues C.H.M., and Ascher D.B. (2023). DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res 51, W122–W128. 10.1093/NAR/GKAD472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Doig A.J., and Baldwin R.L. (1995). N‐ and C‐capping preferences for all 20 amino acids in α‐helical peptides. Protein Science 4, 1325–1336. 10.1002/PRO.5560040708,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Šali D., Bycroft M., and Fersht A.R. (1988). Stabilization of protein structure by interaction of α-helix dipole with a charged side chain. Nature 335, 740–743. 10.1038/335740A0;KWRD=SCIENCE. [DOI] [PubMed] [Google Scholar]
- 72.Sancho J., Serrano L., and Fersht A.R. (1992). Histidine Residues at the N-and C-Termini of α-Helices: Perturbed pKas and Protein Stability. Biochemistry 31, 2253–2258. 10.1021/BI00123A006/ASSET/BI00123A006.FP.PNG_V03. [DOI] [PubMed] [Google Scholar]
- 73.Armstrong K.M., and Baldwin R.L. (1993). Charged histidine affects α-helix stability at all positions in the helix by interacting with the backbone charges. Proc Natl Acad Sci U S A S0, 11337–11340. 10.1073/PNAS.90.23.11337,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Wang Y., and Gu X. (2001). Functional divergence in the caspase gene family and altered functional constraints: statistical analysis and prediction. Genetics 158, 1311–1320. 10.1093/GENETICS/158.3.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Grinshpon R.D., Williford A., Titus‐McQuillan J., and Clay Clark A. (2018). The CaspBase: a curated database for evolutionary biochemical studies of caspase functional divergence and ancestral sequence inference. Protein Science 27, 1857–1870. 10.1002/pro.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Lu A., Li Y., Schmidt F.I., Yin Q., Chen S., Fu T.M., Tong A.B., Ploegh H.L., Mao Y., and Wu H. (2016). Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism. Nat Struct Mol Biol 23, 416–425. 10.1038/NSMB.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Li Y., Fu T.M., Lu A., Witt K., Ruan J., Shen C., and Wu H. (2018). Cryo-EM structures of ASC and NLRC4 CARD filaments reveal a unified mechanism of nucleation and activation of caspase-1. Proc Natl Acad Sci U S A 115, 10845–10852. 10.1073/PNAS.1810524115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Sasidharan R., and Chothia C. (2007). The selection of acceptable protein mutations. Proceedings of the National Academy of Sciences 104, 10080–10085. 10.1073/pnas.0703737104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Tóth-Petróczy Á., and Tawfik D.S. (2011). Slow protein evolutionary rates are dictated by surface–core association. Proceedings of the National Academy of Sciences 108, 11151–11156. 10.1073/pnas.1015994108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Zhou W., Kaneko N., Nakagita T., Takeda H., and Masumoto J. (2021). A comprehensive interaction study provides a potential domain interaction network of human death domain superfamily proteins. Cell Death C Differentiation 2021 28:11 28, 2991–3008. 10.1038/s41418-021-00796-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Ben Chorin A., Masrati G., Kessel A., Narunsky A., Sprinzak J., Lahav S., Ashkenazy H., and Ben-Tal N. (2020). ConSurf-DB: An accessible repository for the evolutionary conservation patterns of the majority of PDB proteins. Protein Science 2S, 258–267. 10.1002/PRO.3779,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Ferrao R., and Wu H. (2012). Helical assembly in the death domain (DD) superfamily. Curr Opin Struct Biol 22, 241–247. 10.1016/J.SBI.2012.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Doolittle R.F. (1981). Similar amino acid sequences: chance or common ancestry? Science (1979) 214, 149–159. 10.1126/SCIENCE.7280687. [DOI] [PubMed] [Google Scholar]
- 84.Rost B. (1999). Twilight zone of protein sequence alignments. Protein Engineering, Design and Selection 12, 85–94. 10.1093/PROTEIN/12.2.85. [DOI] [PubMed] [Google Scholar]
- 85.Chothia C., and Lesk A.M. (1986). The relation between the divergence of sequence and structure in proteins. EMBO J 5, 823–826. 10.1002/J.1460-2075.1986.TB04288.X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Cho N.H., Cheveralls K.C., Brunner A.D., Kim K., Michaelis A.C., Raghavan P., Kobayashi H., Savy L., Li J.Y., Canaj H., et al. (2022). OpenCell: Endogenous tagging for the cartography of human cellular organization. Science (1979) 375. 10.1126/SCIENCE.ABI6983/SUPPL_FILE/SCIENCE.ABI6983_TABLES_S1_TO_S9.ZIP. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Borgeaud A.C., Ganeva I., Klein C., Stooss A., Ross-Kaschitza D., Wu L., Riley J.S., Tait S.W.G., Lemmin T., Kaufmann T., et al. (2024). Large transient assemblies of Apaf1 constitute the apoptosome in cells. bioRxiv, 2024.07.01.600688. 10.1101/2024.07.01.600688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Shen H., Lynch E.M., Akkineni S., Watson J.L., Decarreau J., Bethel N.P., Benna I., Sheffler W., Farrell D., DiMaio F., et al. (2024). De novo design of pH-responsive self-assembling helical protein filaments. Nature Nanotechnology 2024 19:7 1S, 1016–1021. 10.1038/s41565-024-01641-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Sattler M., Schleucher J., and Griesinger C. (1999). Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog Nucl Magn Reson Spectrosc 34, 93–158. 10.1016/S0079-6565(98)00025-9. [DOI] [Google Scholar]
- 90.Ying J., Delaglio F., Torchia D.A., and Bax A. (2017). Sparse multidimensional iterative lineshape-enhanced (SMILE) reconstruction of both non-uniformly sampled and conventional NMR data. J Biomol NMR c8, 101–118. 10.1007/s10858-016-0072-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR c, 277–293. [DOI] [PubMed] [Google Scholar]
- 92.Lee W., Tonelli M., and Markley J.L. (2015). NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 31, 1325–1327. 10.1093/bioinformatics/btu830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Shen Y., and Bax A. (2015). Protein Structural Information Derived from NMR Chemical Shift with the Neural Network Program TALOS-N. Methods in Molecular Biology 12c0, 32. 10.1007/978-1-4939-2239-0_2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Farrow N.A., Muhandiram R., Pascal S.M., Kay L.E., Singer A.U., Forman-Kay J.D., Kay C.M., Gish G., Pawson T., and Shoelson S.E. (1994). Backbone Dynamics of a Free and a Phosphopeptide-Complexed Src Homology 2 Domain Studied by 15N NMR Relaxation. Biochemistry 33, 5984–6003. 10.1021/BI00185A040,. [DOI] [PubMed] [Google Scholar]
- 95.Kay L.E., Keifer P., and Saarinen T. (1992). Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J Am Chem Soc 114, 10663–10665. 10.1021/ja00052a088. [DOI] [Google Scholar]
- 96.Lakomek N.A., Ying J., and Bax A. (2012). Measurement of 15N relaxation rates in perdeuterated proteins by TROSY-based methods. J Biomol NMR 53, 209–221. 10.1007/S10858-012-9626-5/FIGURES/6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Vallurupalli P., Hansen D.F., and Kay L.E. (2008). Structures of invisible, excited protein states by relaxation dispersion NMR spectroscopy. Proceedings of the National Academy of Sciences 105, 11766–11771. 10.1073/pnas.0804221105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Hansen A.L., and Kay L.E. (2014). Measurement of histidine pKa values and tautomer populations in invisible protein states. Proc Natl Acad Sci U S A 111. 10.1073/PNAS.1400577111/-/DCSUPPLEMENTAL/PNAS.201400577SI.PDF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Li S., and Hong M. (2011). Protonation, tautomerization, and rotameric structure of histidine: A comprehensive study by magic-angle-spinning solid-state NMR. J Am Chem Soc 133, 1534–1544. 10.1021/JA108943N,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Blomberg F., Maurer W., and Rüterjans H. (1977). Nuclear Magnetic Resonance Investigation of 15N-Labeled Histidine in Aqueous Solution. J Am Chem Soc SS, 8149–8159. 10.1021/JA00467A005/ASSET/JA00467A005.FP.PNG_V03. [DOI] [PubMed] [Google Scholar]
- 101.Markley J.L. (1975). Observation of Histidine Residues in Proteins by Means of Nuclear Magnetic Resonance Spectroscopy. Acc Chem Res 8, 70–80. 10.1021/AR50086A004/ASSET/AR50086A004.FP.PNG_V03. [DOI] [Google Scholar]
- 102.Newville M., Otten R., Nelson A., Stensitzki T., Ingargiola A., Allan D., Fox A., Carter F., and Rawlik M. LMFIT: Non-Linear Least-Squares Minimization and Curve-Fitting for Python. 10.5281/ZENODO.15014437. [DOI] [Google Scholar]
- 103.De La Torre J.G., Huertas M.L., and Carrasco B. (2000). HYDRONMR: Prediction of NMR Relaxation of Globular Proteins from Atomic-Level Structures and Hydrodynamic Calculations. Journal of Magnetic Resonance 147, 138–146. 10.1006/jmre.2000.2170. [DOI] [PubMed] [Google Scholar]
- 104.Maciejewski M.W., Schuyler A.D., Gryk M.R., Moraru I.I., Romero P.R., Ulrich E.L., Eghbalnia H.R., Livny M., Delaglio F., and Hoch J.C. (2017). NMRbox: A Resource for Biomolecular NMR Computation. Biophys J 112, 1529–1534. 10.1016/J.BPJ.2017.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Berendsen H.J.C., van der Spoel D., and van Drunen R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun S1, 43–56. 10.1016/0010-4655(95)00042-E. [DOI] [Google Scholar]
- 106.Lindorff-Larsen K., Piana S., Palmo K., Maragakis P., Klepeis J.L., Dror R.O., and Shaw D.E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins: Structure, Function and Bioinformatics 78, 1950–1958. 10.1002/PROT.22711,. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Horn H.W., Swope W.C., Pitera J.W., Madura J.D., Dick T.J., Hura G.L., and Head-Gordon T. (2004). Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew. Journal of Chemical Physics 120, 9665–9678. 10.1063/1.1683075,. [DOI] [PubMed] [Google Scholar]
- 108.Bussi G., Donadio D., and Parrinello M. (2007). Canonical sampling through velocity rescaling. Journal of Chemical Physics 12c. 10.1063/1.2408420,. [DOI] [PubMed] [Google Scholar]
- 109.Berendsen H.J.C., Postma J.P.M., Van Gunsteren W.F., Dinola A., and Haak J.R. (1984). Molecular dynamics with coupling to an external bath. J Chem Phys 81, 3684–3690. 10.1063/1.448118. [DOI] [Google Scholar]
- 110.Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., and Pedersen L.G. (1995). A smooth particle mesh Ewald method. J Chem Phys 103, 8577–8593. 10.1063/1.470117. [DOI] [Google Scholar]
- 111.Parrinello M., and Rahman A (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52, 7182–7190. 10.1063/1.328693. [DOI] [Google Scholar]
- 112.Punjani A., Rubinstein J.L., Fleet D.J., and Brubaker M.A. (2017). cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nature Methods 2017 14:3 14, 290–296. 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
- 113.Scheres S.H.W. (2012). RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol 180, 519–530. 10.1016/J.JSB.2012.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Madeira F., Madhusoodanan N., Lee J., Eusebi A., Niewielska A., Tivey A.R.N., Lopez R., and Butcher S. (2024). The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024. Nucleic Acids Res 52, W521–W525. 10.1093/NAR/GKAE241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Needleman S.B., and Wunsch C.D. (1970). A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 48, 443–453. 10.1016/0022-2836(70)90057-4. [DOI] [PubMed] [Google Scholar]
- 116.Elofsson A. (2002). A study on protein sequence alignment quality. Proteins: Structure, Function and Genetics 4c, 330–339. 10.1002/PROT.10043,. [DOI] [PubMed] [Google Scholar]
- 117.Cock P.J.A., Antao T., Chang J.T., Chapman B.A., Cox C.J., Dalke A., Friedberg I., Hamelryck T., Kauff F., Wilczynski B., et al. (2009). Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422–1423. 10.1093/bioinformatics/btp163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Kabsch W., and Sander C. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features. Biopolymers 22, 2577–2637. 10.1002/BIP.360221211;PAGE:STRING:ARTICLE/CHAPTER. [DOI] [PubMed] [Google Scholar]
- 119.Jumper J., Evans R., Pritzel A., Green T., Figurnov M., Ronneberger O., Tunyasuvunakool K., Bates R., Žídek A., and Potapenko A. (2021). Highly accurate protein structure prediction with AlphaFold. Nature 5Sc, 583–589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Varadi M., Anyango S., Deshpande M., Nair S., Natassia C., Yordanova G., Yuan D., Stroe O., Wood G., Laydon A., et al. (2021). AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 10.1093/NAR/GKAB1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Beltran A., Jiang X., Shen Y., and Lehner B. (2025). Site-saturation mutagenesis of 500 human protein domains. Nature 2025 637:8047 c37, 885–894. 10.1038/s41586-024-08370-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Remmert M., Biegert A., Hauser A., and Söding J. (2012). HHblits: Lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat Methods S, 173–175. 10.1038/NMETH.1818;SUBJMETA=114,129,1647,2044,48,631;KWRD=BIOINFORMATICS,PROTEIN+DATABASES. [DOI] [PubMed] [Google Scholar]
- 123.Steinegger M., and Söding J. (2017). MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat Biotechnol 35, 1026–1028. 10.1038/NBT.3988;SUBJMETA=114,171,2184,2404,326,631,794;KWRD=ENVIRONMENTAL+MICROBIOLOGY,FUNCTIONAL+CLUSTERING,SEQUENCE+ANNOTATION,SOFTWARE. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





